Related Experiment Videos
Effects of mepirizole and basic antiinflammatory drugs on HCl-ethanol-induced gastric lesions in rats
H Tanaka1, M Nakagawa, K Takeuchi
1Department of Applied Pharmacology, Kyoto Pharmaceutical University, Japan.
Abstract:
Mepirozole, a basic antiinflammatory drug and duodenal ulcerogen in laboratory animals, macroscopically protected the gastric mucosa of rats from HCl-ethanol-induced damage in a dose-dependent manner. These effects were evident when the agent was given orally, intraperitoneally, or subcutaneously at 3 or 10 mg/kg 0.5 hr before HCl-ethanol administration. Histologically, the surface epithelial and pit cells were not protected by mepirizole, but most of the mucosal cells located in the deeper portions were well preserved. Gastric acid secretion in the pylorus-ligated or acute fistula preparation was not affected by 10 mg/kg of mepirizole. Gastric motility determined by a balloon method was dose-dependently inhibited by the agent. Mepirizole protection was significantly reduced by pretreatment with subcutaneous indomethacin (5 mg/kg) and N-ethylmaleimide (10 mg/kg). The gastric motility inhibited by mepirizole was not reversed by indomethacin and N-ethylmaleimide treatment. These results suggest that the mechanism underlying mepirizole protection relates to both endogenous prostaglandins and sulfhydryl compounds present in the gastric mucosa, but does not relate to an inhibition of gastric motility. Dulcerozine and other basic antiinflammatory drugs (tiaramide, tinoridine, and benzydamine) given either orally or intraperitoneally at 10-100 mg/kg also dose-dependently prevented the development of HCl-ethanol-induced lesions. Mepirizole and other basic antiinflammatory drugs are cytoprotective in the rat stomach.
Insights
Mepirozole, a basic anti-inflammatory drug, protects the rat gastric mucosa from damage. Its cytoprotective mechanism involves prostaglandins and sulfhydryl compounds, not altered gastric motility.
Area of Science:
- Pharmacology
- Gastroenterology
- Drug Discovery
Background:
- Mepirozole is a basic anti-inflammatory drug known to cause duodenal ulcers in animals.
- Gastric mucosal protection is crucial for preventing ulcers and inflammation.
Purpose of the Study:
- To investigate the cytoprotective effects of mepirizole on the gastric mucosa.
- To elucidate the mechanism underlying mepirizole's protective action.
Main Methods:
- Rats were administered HCl-ethanol to induce gastric damage.
- Mepirozole was administered via oral, intraperitoneal, or subcutaneous routes.
- Gastric acid secretion and motility were measured. Effects of indomethacin and N-ethylmaleimide were assessed.
Main Results:
- Mepirozole dose-dependently protected the gastric mucosa from HCl-ethanol-induced damage.
- Protection was observed in deeper mucosal cells, not surface or pit cells.
- Gastric acid secretion was unaffected, but motility was inhibited.
- Protection was reduced by indomethacin and N-ethylmaleimide, suggesting involvement of prostaglandins and sulfhydryl compounds.
Conclusions:
- Mepirozole exhibits significant cytoprotective effects on the rat gastric mucosa.
- The mechanism involves endogenous prostaglandins and sulfhydryl compounds.
- Inhibition of gastric motility is not the primary mechanism of mepirizole's protection.